Maynard Um
-
-
-
-
-
-
-
Maravai LifeSciences (MRVI) Misses Q2 EPS by 1c, withdraws guidance
-
-
-
-
-
-
-
MRVI DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action - MRVI
-
-
-
-
-
-
-
MRVI DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action - MRVI
-
-
-
-
-
-
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
-
-
-
-
-
-
-
ROSEN, A RANKED AND LEADING FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRVI
-
-
-
-
-
-
-
Faruqi & Faruqi Reminds Maravai LifeSciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - MRVI
-
-
-
-
-
-
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRVI
-
422,490 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

